As the Ozak AI is the Top emerging AI based token in the Crypto Market. Many presale tokens are in the Crypto market, but Ozak AI is unique among them due to itsAs the Ozak AI is the Top emerging AI based token in the Crypto Market. Many presale tokens are in the Crypto market, but Ozak AI is unique among them due to its

From Presale to Post-Listing, Ozak AI’s Growth Curve Indicates Strong Compounding Potential Over a 24–36 Month Horizon

2026/04/08 22:45
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

As the Ozak AI is the Top emerging AI based token in the Crypto Market. Many presale tokens are in the Crypto market, but Ozak AI is unique among them due to its strong presale momentum and Advanced AI technology. The token has raised over $6 million in presale funding in a short period of time. This achievement from the presale token shows how the token is gaining the attention and confidence of the investors even in the Bear market. Analysts suggest that the tokens will soon be listed on the major exchange in a short period of time, and the Growth Curve indicates strong compounding over 24 to 36 months. 

Presale Phase: The Base Layer of the Growth Curve

The Ozak AI is currently priced at $0.014 in its 7th Presale phase. The token has increased 14x from the initial phase, which was launched at the price of $0.001. The Token has sold over 1.16 billion in OZ tokens so far. The Ozak AI’s Presale Phases are sold out rapidly due to the high demand and limited supply in the Presale Phases. The Token has raised over $6.6 million in Presale funding. Analysts predict that the token is nearing the listing, and once it is listed, the token will gain a massive reach and capture these gains. The investors are rushing to the Current Ozak AI Presale to gain a massive return. The target price of the token to be listed on the major exchanges is $1.

Technology Progress as a Compounding Driver

Ozak AI stands unique among the other AI-based cryptos, as it merges AI and blockchain to produce AI predictive tools that analyze the real-time blockchain data, automated decisions, and decentralized AI integration. Strong features of Ozak AI consist of the Ozak Streaming Network (OSN), which is a real-time data ingestion layer built on Apache Kafka and Apache Flink. It processes millions of market events per second and bridges on-chain and off-chain data for price feeds and news. The other feature is the Ozak Data Vaults, which are encrypted NoSQL database vaults for financial data. It is controlled by the smart contracts for user permissions and enables fast retrieval for real-time analytics.

Post-Listing Projection for Ozak AI as per the Analysts

Currently the Ozak AI is priced at $0.014. Assuming the investment of $200 in The Ozak AI at the Current Phase could secure 14,285 OZ tokens. If the token reaches the listing Phase and is listed at $1, then the $200 investment would be $14,285 with 71x growth and a 7000% increase. Once the token has been listed in the major exchanges, then the Token gets more exposure, and many investors would secure the token. This makes the tokens reach the projected price of $3 by 2027; then the secured tokens’ worth would be $42,857 with 214x growth and a 21,320% increase. If the tokens maintain the small momentum and the AI has dominated the entire Crypto market then the Token could reach the projected price of $5 by 2028, and then the $200 investment would be turned into $71,428 with 357x growth and 35,614%. This shows how the token is gaining massive ROI after it is listed in the major exchanges.

Strategic Partnerships Reinforce the Curve

The Ozak AI’s collaboration with the top AI and Blockchain firms helps investors to build trust in the token. This makes the ecosystem stronger and pulls many investors’ interest into the token.  Partnering with Hive Intel, which is a multichain data API, the Ozak AI predictive tools can now analyze the on-chain behavior deeper, which includes NFT, Defi events.  Another partnership with Echobit, which is an exchange design for microsecond-order matching, merging with Ozak AI’s 30-ms market prediction. 

Conclusion: Growth Curves Matter More Than Headlines

The Ozak AI is mainly focusing on the long-term growth rather than the short-term hype. The Ozak AI’s analysts Projection is really achievable if the token maintains the same momentum and the market favors it. The Token has strong presale growth, advanced AI technology, and strategic Partnerships which makes the Token to be listed soon on the major exchanges and will reach the projected price by turning the small investment into a massive return for the early investors who invest at the current Presale Phase. 

  • Website: https://ozak.ai/ 
  • Twitter/X: https://x.com/OzakAGI 
  • Telegram: https://t.me/OzakAGI   

Disclaimer: TheNewsCrypto does not endorse any content on this page. The content depicted in this Press Release does not represent any investment advice. TheNewsCrypto recommends our readers to make decisions based on their own research. TheNewsCrypto is not accountable for any damage or loss related to content, products, or services stated in this Press Release.

Market Opportunity
Based Logo
Based Price(BASED)
$0.06776
$0.06776$0.06776
-4.22%
USD
Based (BASED) Live Price Chart

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Share
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Share
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage